13F-HR filed by RTW INVESTMENTS, LP
RTW INVESTMENTS, LP filed this 13F-HR for the quarter ended 2015-09-30, filed 2015-11-13, with 44 holding rows worth $317,068,000.
- Accession
- 0000909012-15-000338
- Filer
- CIK 1493215
- Filed
- 2015-11-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2015
A holdings report, 47 entries on the cover page, a total value of $317,068,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $317,068,000 with VALUE read as thousands by filing date, 13F file number 028-16670. A later restatement replaced it, so the quarter does not use it. The resolved quarter.
Other managers
- included managerRTW MASTER FUND, LTD.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 525,713 | $42,246,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 298,674 | $32,953,000 | thousands by filing date | |
| LA JOLLA PHARMACEUTICAL CO | 503459604 | COM PAR $.0001 2 | 1,064,247 | $29,575,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 2,194,989 | $25,023,000 | thousands by filing date | |
| KITE PHARMA INC | 49803L109 | COM | 369,850 | $20,593,000 | thousands by filing date | |
| ACHILLION PHARMACEUTICALS IN | 00448Q201 | COM | 2,551,261 | $17,629,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 474,730 | $16,340,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 1,975,229 | $16,217,000 | thousands by filing date | |
| BLUEBIRD BIO INC | 09609G100 | COM | 149,325 | $12,775,000 | thousands by filing date | |
| Arrowhead Research Corp | 42797209 | COM NEW | 2,065,962 | $11,900,000 | thousands by filing date | The CUSIP as filed is malformed. |
| FIVE PRIME THERAPEUTICS INC. | 33830X104 | Common Stock | 703,267 | $10,823,000 | thousands by filing date | |
| AGENUS INC | 00847G705 | COM NEW | 2,052,915 | $9,443,000 | thousands by filing date | |
| Atara Biotherapeutics Inc. | 46513107 | COM | 259,317 | $8,153,000 | thousands by filing date | The CUSIP as filed is malformed. |
| CELLDEX THERAPEUTICS INC NEW | 15117B103 | COM | 707,957 | $7,462,000 | thousands by filing date | |
| SYMMETRY SURGICAL INC | 87159G100 | COM | 795,422 | $7,079,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 97,454 | $5,769,000 | thousands by filing date | |
| CORIUM INTL INC | 21887L107 | COM | 566,648 | $5,298,000 | thousands by filing date | |
| OMEROS CORP | 682143102 | COM | 482,831 | $5,292,000 | thousands by filing date | |
| REGENXBIO INC | 75901B107 | COM | 202,933 | $4,471,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 91,060 | $3,839,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 7,500 | $2,588,000 | thousands by filing date | call |
| LIPOCINE INC NEW | 53630X104 | CMN | 209,333 | $2,476,000 | thousands by filing date | |
| INVUITY INC | 46187J205 | COM NEW | 175,000 | $2,453,000 | thousands by filing date | |
| DYAX CORP | 26746E103 | COM | 113,641 | $2,169,000 | thousands by filing date | |
| PRESBIA PLC | G7234P100 | SHS | 350,000 | $1,918,000 | thousands by filing date | |
| CATALYST | 14888D109 | COM | 380,806 | $1,775,000 | thousands by filing date | |
| REPROS THERAPEUTICS INC | 76028H209 | COM | 229,364 | $1,704,000 | thousands by filing date | |
| VBI VACCINES INC CDA | 91790E102 | Stock | 640,458 | $1,691,000 | thousands by filing date | |
| ORASURE TECHNOLOGIES INC | 68554V108 | COM | 322,996 | $1,434,000 | thousands by filing date | |
| CYTRX CORP | 232828509 | COM PAR $.001 | 446,714 | $1,059,000 | thousands by filing date | |
| MASIMO CORP COM | 574795100 | Stock | 25,900 | $999,000 | thousands by filing date | |
| NEWLINK GENETICS CORP | 651511107 | COM | 27,870 | $999,000 | thousands by filing date | |
| VERADIGM INC | 01988P108 | COMMON STOCK | 48,000 | $595,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 1,971 | $425,000 | thousands by filing date | call |
| NIVALIS THERAPEUTICS INC | 65481J109 | COM | 30,000 | $389,000 | thousands by filing date | |
| BIOPHARMX CORP | 09072X101 | COM | 370,636 | $382,000 | thousands by filing date | |
| NATERA INC COM | 632307104 | Stock | 31,236 | $339,000 | thousands by filing date | |
| GENOMIC HEALTH, INC. | 37244C101 | COM | 14,777 | $313,000 | thousands by filing date | |
| ENDOLOGIX INC | 29266S106 | COM | 14,777 | $181,000 | thousands by filing date | |
| VERACYTE INC COM | 92337F107 | Stock | 25,000 | $117,000 | thousands by filing date | |
| ADAPTIMMUNE THERAPEUTICS PLC | 00653A107 | SPONDS ADR | 6,923 | $83,000 | thousands by filing date | |
| MERIDIAN BIOSCIENCE INC | 589584101 | COMMON STOCK | 1,252 | $50,000 | thousands by filing date | call |
| UNITED STATES OIL FUND LP | 91232N108 | UNITS | 13,850 | $42,000 | thousands by filing date | call |
| BERKSHIRE HATHAWAY INC. CLASS B | 84670702 | COM | 50 | $7,000 | thousands by filing date | The CUSIP as filed is malformed. |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000909012-15-000338 | this filing | 2015-11-13 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001493152-16-010243 | base | 2016-05-24 | acceptance time not in the bulk data set |